Hamilton Lane Incorporated (HLNE)
| Market Cap | 4.78B -38.7% |
| Revenue (ttm) | 758.99M +6.5% |
| Net Income | 249.18M +14.6% |
| EPS | 5.92 +9.5% |
| Shares Out | 56.14M |
| PE Ratio | 14.41 |
| Forward PE | 13.77 |
| Dividend | $2.40 (2.81%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 489,918 |
| Open | 84.36 |
| Previous Close | 85.90 |
| Day's Range | 84.19 - 87.10 |
| 52-Week Range | 71.88 - 161.13 |
| Beta | 1.17 |
| Analysts | Buy |
| Price Target | 129.29 (+51.73%) |
| Earnings Date | Aug 4, 2026 |
About HLNE
Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. The firm manages alternative investment strategies like direct credit, direct, fund of fund, evergreen and real assets. For primary and secondary fund of fund investments, the firm focuses to invest in private equity, buyout, special situations, credit, growth equity, middle market, mature, turnaroun... [Read more]
Financial Performance
In fiscal year 2026, Hamilton Lane's revenue was $758.99 million, an increase of 6.46% compared to the previous year's $712.96 million. Earnings were $249.18 million, an increase of 14.61%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for HLNE stock is "Buy." The 12-month stock price target is $129.29, which is an increase of 51.73% from the latest price.
News
Hamilton Lane price target lowered to $174 from $176 at Oppenheimer
Oppenheimer lowered the firm’s price target on Hamilton Lane (HLNE) to $174 from $176 and keeps an Outperform rating on the shares. The firm adjusted targets in the alternative asset…
Hamilton Lane price target lowered to $94 from $102 at BMO Capital
BMO Capital lowered the firm’s price target on Hamilton Lane (HLNE) to $94 from $102 and keeps an Outperform rating on the shares as part of a broader research note,…
Hamilton Lane price target lowered to $105 from $115 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Hamilton Lane (HLNE) to $105 from $115 and keeps an Outperform rating on the shares.
Hamilton Lane Incorporated to Announce First Quarter Fiscal 2027 Results on August 4, 2026
CONSHOHOCKEN, Pa., July 7, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (Nasdaq: HLNE) is scheduled to release financial results for the first fiscal quarter ended June 30, 2026 before the market o...
Hamilton Lane planning first yuan-denominated fund, Bloomberg says
Hamilton Lane (HLNE) is preparing its first yuan-denominated fund to target discounted Chinese assets, Bloomberg’s Lulu Yilun Chen and Echo Wong report, citing people familiar with the matter. The U.S...
Hamilton Lane Holds Final Close of Sixth Direct Equity Fund, Raising $3.8 Billion in and alongside the Fund
CONSHOHOCKEN, Pa., July 1, 2026 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced it has closed on $3.8 billion in total commitment...
Hamilton Lane price target lowered to $128 from $148 at Goldman Sachs
Goldman Sachs analyst Alexander Blostein lowered the firm’s price target on Hamilton Lane (HLNE) to $128 from $148 and keeps a Buy rating on the shares. Capital markets stocks are…
Hamilton Lane announces strategic integration with Hamilton Lane
Gridline announced a strategic partnership and technology integration with Hamilton Lane (HLNE). “One of the most important steps in institutional-quality due diligence is understanding how a fund man...
Gridline Announces Strategic Integration With Hamilton Lane, Expanding Private Markets Benchmarking Capabilities
ATLANTA--(BUSINESS WIRE)--Gridline, the turnkey platform wealth management firms rely on to manage the private markets lifecycle, today announced a strategic partnership and technology integration wit...
Private Asset Manager Hamilton Lane Rebuts Its Industry's Critics
Hamilton Lane says critics misunderstand how private-equity fund stakes are valued, defending the industry's practice of booking gains on discounted secondary-market purchases.
Hamilton Lane price target lowered to $102 from $108 at BMO Capital
BMO Capital analyst Brennan Hawken lowered the firm’s price target on Hamilton Lane (HLNE) to $102 from $108 and keeps an Outperform rating on the shares. The firm cites the…
Hamilton Lane price target raised to $179 from $171 at Oppenheimer
Oppenheimer analyst Chris Kotowski raised the firm’s price target on Hamilton Lane (HLNE) to $179 from $171 and keeps an Outperform rating on the shares. In a weak group, Hamilton…
Hamilton Lane price target lowered to $115 from $120 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Hamilton Lane (HLNE) to $115 from $120 and keeps an Outperform rating on the shares. The Q4 results cleared a relatively low…
Hamilton Lane price target raised to $148 from $143 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Hamilton Lane (HLNE) to $148 from $143 and keeps a Buy rating on the shares after its Q4 earnings beat. The firm…
Hamilton Lane Earnings Call Transcript: Q4 2026
Total asset footprint reached $1 trillion, with strong growth in AUM, fee-related earnings, and evergreen products. Dividend increased 11%, and new product launches and digital investments support continued expansion. Institutional flows and exit activity are expected to rise.
Hamilton Lane Earnings release: Q4 2026
Hamilton Lane released its Q4 2026 earnings on May 21, 2026, summarizing the period's financial results.
Hamilton Lane Slides: Q4 2026
Hamilton Lane has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 21, 2026.
Hamilton Lane Annual report: Q4 2026
Hamilton Lane has published its Q4 2026 annual report on May 21, 2026.
Hamilton Lane reports Q4 non-GAAP EPS $1.49, consensus $1.43
Reports Q4 revenue $193.57M, consensus $203.05M. Assets under management and fee-earning assets under management were $142B and $82B, respectively, as of March 31, 2026, increases of 3% and 13%, respe...
Hamilton Lane increases share repurchase program to $100M
Hamilton Lane (HLNE) approved an increase in the authorization under the Company’s existing stock repurchase program to $100M of its Class A common stock, net of amounts already repurchased under…
HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS
CONSHOHOCKEN, Pa., May 21, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the fourth quarter and full fisca...
Hamilton Lane management to meet with Oppenheimer
Meeting to be held on May 26-27 hosted by Oppenheimer.
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commerc...
Hamilton Lane price target lowered to $148 from $166 at JPMorgan
JPMorgan analyst Kenneth Worthington lowered the firm’s price target on Hamilton Lane (HLNE) to $148 from $166 and keeps an Overweight rating on the shares. The firm updated the company’s…
Power Sustainable Completes Sale of Minority Stake in Big Sky Wind to Institutional Partners
MONTREAL, April 29, 2026 /PRNewswire/ - Power Sustainable Energy Infrastructure ("PSEI"), the renewable energy infrastructure platform of Power Sustainable, today announced it completed the sale of a ...